1. Home
  2. LOCL vs SER Comparison

LOCL vs SER Comparison

Compare LOCL & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Local Bounti Corporation

LOCL

Local Bounti Corporation

HOLD

Current Price

$2.53

Market Cap

54.0M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.25

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCL
SER
Founded
2021
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.0M
42.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LOCL
SER
Price
$2.53
$3.25
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
20.6K
17.8K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,978,000.00
$116,000.00
Revenue This Year
$36.93
$134.46
Revenue Next Year
$82.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.61
N/A
52 Week Low
$1.18
$3.23
52 Week High
$5.75
$7.92

Technical Indicators

Market Signals
Indicator
LOCL
SER
Relative Strength Index (RSI) 49.60 30.89
Support Level $2.27 $3.68
Resistance Level $2.80 $4.26
Average True Range (ATR) 0.21 0.26
MACD 0.02 -0.02
Stochastic Oscillator 51.25 1.94

Price Performance

Historical Comparison
LOCL
SER

About LOCL Local Bounti Corporation

Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: